Iloprost , marketed under the name Tyvaso , is used for pulmonary hypertension .
Iloprost was the only inhaled form of prostacyclin approved for use in the US and Europe , until the inhaled form of treprostinil was approved by the FDA in July 2009.
Pulmonary hypertension